Tevogen Bio Hldgs Inc.
13F holders, Q1 2024 (March 31)5holders
$4.53avg. 13F price*
At the end of Q1 2024, 5 institutions reported holding Tevogen Bio Hldgs Inc. in their 13F filings. The largest holders were Portland Global Advisors LLC ($21.7M), Polar Asset Management Partners Inc. ($6.2M) and Cantor Fitzgerald, L. P. ($2.8M).
- Company
- Tevogen Bio Hldgs Inc.
- CUSIP
- 88165K101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $30.7M |
| Exits | 0 | $0 |
Ownership 5 holders
| Portland Global Advisors LLC | 2.96% | New | 5,782,209 | $21.7M |
| Polar Asset Management Partners Inc. | 0.22% | New | 334,615 | $6.2M |
| Cantor Fitzgerald, L. P. | 0.67% | New | 650,000 | $2.8M |
| HRT Financial LP | 0.00% | New | 12,278 | $45K |
| JPMorgan Chase & Co. | 0.00% | New | 30 | $112 |
"% of holder's portfolio" is TEVOGEN BIO HLDGS INC's weight in each manager's 13F, not the share of Tevogen Bio Hldgs Inc. the manager owns.